News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
David S. Miller: Why Cisplatin should not be added to radiotherapy for certain recurrent Endometrial Cancer
Photo taken from David Scott Miller/X
Jul 20, 2024, 22:54

David S. Miller: Why Cisplatin should not be added to radiotherapy for certain recurrent Endometrial Cancer

David Scott Miller, Gynaecologic Oncologist and Professor at Department of Obstetrics and Gynaecology at UT Southwestern Medical Center, shared a post on X about a recent paper by Ann H.Klopp et al., commenting:

“More on the results of NRG Oncology, The GOG Foundation Inc. 238, Why Cisplatin should not be added to radiotherapy for certain recurrent Endometrial Cancer. Now in print in Journal of Clinical Oncology. From International Journal of Gynaecological Cancer.”

“Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial”

Journal: ASCO Publications.

Authors: Ann H. Klopp, Danielle Enserro, Matthew Powell, Marcus Randall, Julian C. Schink, Robert S. Mannel, Laura Holman, David Bender, Christina L. Kushnir, Floor Backes, Susan L. Zweizig, Steven Waggoner, Kristin A. Bradley, Lana DeSouza Lawrence, Parviz Hanjani,Christopher J. Darus, William Small Jr., Higinia R. Cardenes, Jonathan M. Feddock, David S. Miller.

David Scott Miller

Additional information
Source: David Scott Miller/X

Ann H. Klopp cancer Cisplatin Danielle Enserro David Scott Miller Endometrial cancer International Journal of Gynaecological Cancer Jonathan M. Feddock Journal of Clinical Oncology Matthew Powell NRG Oncology OncoDaily Oncology radiotherapy The GOG Foundation Inc. UT Southwestern Medical Center
Special Coverage
Blog
Dec 21, 2024, 14:10
Arif Kamal: Ensuring all people have access to the cancer navigation services that will help them live more and better days
Blog
Dec 21, 2024, 14:06
The Accelerate 2025 Annual Conference Agenda Is Here!
Blog
Dec 21, 2024, 14:03
Pioneer the future of discovery and innovation with a fully funded Bicentenary PhD Studentship at The University of Manchester
Blog
Dec 21, 2024, 14:00
NCI Division of Cancer Prevention - DHT Derived Biomarkers and COAs for Remote Monitoring and Endpoint Development
Blog
Dec 21, 2024, 13:51
The ESMO President Letter emphasises the importance of collective action to shape the future of oncology
Blog
Dec 21, 2024, 13:48
Overcoming recurrence: How research is bringing new hope for breast cancer patients - The Institute of Cancer Research
Blog
Dec 21, 2024, 13:46
IARC - Cancer Incidence in Five Continents, Vol XII
Blog
Dec 21, 2024, 13:43
National University Cancer Institute, Singapore clinicians had the exciting opportunity to present their work at the ESMO Asia 2024
Blog
Dec 21, 2024, 13:40
UICC - Welcoming the newest member, The World Hepatitis Alliance
Blog
Dec 21, 2024, 13:35
Pediatric Cancer and Blood Disorders Center of Armenia - Prioritizing the continuous education and knowledge exchange of the medical staff
Blog
Dec 21, 2024, 13:33
SIOP Europe - International Childhood Cancer Day 2025
Blog
Dec 21, 2024, 13:29
Canadian Cancer Society - How 5 organizations are working to take on cancer’s biggest issues